CK-2127107

· Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CK-2127107, covering 2020-08-31 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility [Phase 1]

See pricing